Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China

Addictive Behaviors

Volumn 38, Issue 1, 2013, Pages 1424-1430

  Zhang, Yangyang ^a   Lu, Changli ^a   Zhang, Jun ^a   Hu, Li ^a   Song, Hui ^b   Li, Jing ^a   Kang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b Third Hospital of Mianyang   (China)

Author keywords

Amphetamine type stimulants; Gender; Ketamine

Indexed keywords

3, 4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE TYPE STIMULANT; CENTRAL STIMULANT AGENT; KETAMINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ADULT; ANXIETY DISORDER; ARTICLE; CHINA; COGNITIVE DEFECT; COMORBIDITY; DSM-IV; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MOOD DISORDER; MULTIPLE DRUG ABUSE; PSYCHOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SUBSTANCE ABUSE; TOBACCO;

ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; ANESTHETICS, DISSOCIATIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHINA; COMORBIDITY; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMANS; KETAMINE; MALE; MARITAL STATUS; MENTAL DISORDERS; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84868382870     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2012.06.024     Document Type: Article

References (56)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. Fourth Edition.
2. Bao Y.P., Liu Z.M. Currents situation and trends of drug abuse and HIV/AIDS in China. HIV Therapy 2009, 3:237-240.
3. Brady K.T., Grice D.E., Dustan L., Randall C. Gender differences in substance use disorders. The American Journal of Psychiatry 1993, 150:1707-1711.
4. Brady K.T., Randall C.L. Gender differences in substance use disorders. The Psychiatric Clinics of North America 1999, 22:241-252.
5. Brecht M.L., O'Brien A., von Mayrhauser C., Anglin M.D. Methamphetamine use behaviors and gender differences. Addictive Behaviors 2004, 29:89-106.
6. Burrows K.B., Gudelsky G., Yamamoto B.K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. European Journal of Pharmacology 2000, 398:11-18.
7. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., Hsiao C.C., et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine 2003, 33:1407-1414.
8. Chiang S.C., Chan H.Y., Chang Y.Y., Sun H.J., Chen W.J., Chen C.K. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry and Clinical Neurosciences 2007, 61:105-111.
9. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2007, 64:566-576.
10. Curran H.V., Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 2000, 95:575-590.
11. Deng C., Lai Y., Zeng X.F., Xu J., Yang Y., Li Z. The characteristics of methamphetamine abuse population in Yunnan Province, P.R. China. Progress in Modern Biomedicine 2009, 9:558-560.
12. Devaud L.L., Alele P. Differential effects of chronic ethanol administration and withdrawal on gamma-aminobutyric acid type A and NMDA receptor subunit proteins in male and female rat brain. Alcoholism, Clinical and Experimental Research 2004, 28:957-965.
13. Dillon P., Copeland J., Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug and Alcohol Dependence 2003, 69:23-28.
14. Dluzen D.E., Liu B. Gender differences in methamphetamine use and responses: A review. Gender Medicine 2008, 5:24-35.
15. Fantegrossi W.E., Ciullo J.R., Wakabayashi K.T., De La Garza R., Traynor J.R., Woods J.H. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience 2008, 151:533-543.
16. Fridell M., Hesse M., Jaeger M.M., Kuhlhorn E. Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: Relation to type of substance and type of crime. Addictive Behaviors 2008, 33:799-811.
17. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacological Reviews 2003, 55:463-508.
18. Gustafsson B., Ding S. Unemployment and the rising number of non-workers in urban China: Causes and distributional consequences. CIBC centre for human capital and productivity working papers 2011, University of Western Ontario.
19. Hao W., Xiao S., Liu T., Young D., Chen S., Zhang D., et al. The second National Epidemiological Survey on illicit drug use at six high-prevalence areas in China: Prevalence rates and use patterns. Addiction 2002, 97:1305-1315.
20. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Molecular Psychiatry 2004, 9(984-997):979.
21. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry 1991, 148:1301-1308.
22. Jevtovic-Todorovic V., Wozniak D.F., Benshoff N.D., Olney J.W. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Research 2001, 895:264-267.
23. Keyes K.M., Martins S.S., Hasin D.S. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 2008, 97:139-149.
24. Krystal J.H., Perry E.B., Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function. Archives of General Psychiatry 2005, 62:985-994.
25. Lankenau S.E., Clatts M.C. Patterns of polydrug use among ketamine injectors in New York City. Substance Use & Misuse 2005, 40:1381-1397.
26. Lex B.W. Gender differences and substance abuse. Advances in Alcohol & Substance Abuse 1991, 4:225-296.
27. Li J., Ha T.H., Zhang C., Liu H. The Chinese government's response to drug use and HIV/AIDS: A review of policies and programs. Harm Reduct Journal 2010, 7:4.
28. Li J.H., Vicknasigam B., Cheung Y.W., Zhou W., Nurhidayat A.W., Jarlais D.C.D., et al. To use or not to use: An update on licit and illicit ketamine use. Substance Abuse and Rehabilitation 2011, 2:11-20.
29. Liechti M.E., Gamma A., Vollenweider F.X. Gender differences in the subjective effects of MDMA. Psychopharmacology 2001, 154:161-168.
30. Lin S.K., Ball D., Hsiao C.C., Chiang Y.L., Ree S.C., Chen C.K. Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan. Psychiatry and Clinical Neurosciences 2004, 58:206-212.
31. Liu Z.M., Cao J.Q., Lu X.X., Mu Y., Lian Z. Epidemiological study of central stimulants and other related psychoactive substance abuse. Chinese Journal of Drug Dependence 2002, 11:286-293.
32. Liu Z., Lian Z., Zhao C. Drug use and HIV/AIDS in China. Drug and Alcohol Review 2006, 25:173-175.
33. McGrath J., Saha S., Chant D., Welham J. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 2008, 30:67-76.
34. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: A literature review. Harvard Review of Psychiatry 2005, 13:141-154. 10.1080/10673220591003605.
35. Milani R.M., Parrott A.C., Turner J.J., Fox H.C. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addictive Behaviors 2004, 29:965-971.
36. Momen K., Kanato M. Risk factor associated with club drug users among adolescents in Nong Khai and Udon Thani Provinces, Thailand. Pakistan Journal of Social Sciences 2011, 8:47-51.
37. Moore K., Measham F. Ketamine use: Minimising problems and maximising pleasure. Drugs and Alcohol Today 2009, 6:29-32.
38. Morgan C.J., Curran H.V. Acute and chronic effects of ketamine upon human memory: A review. Psychopharmacology 2006, 188:408-424.
39. Morgan C.J., Muetzelfeldt L., Curran H.V. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study. Addiction 2010, 105:121-133.
40. Morgan C.J., Rossell S.L., Pepper F., Smart J., Blackburn J., Brandner B., et al. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 2006, 59:265-272.
41. Parrott A., Evans L., Howells J., Robart R. Cocaine vs ecstasy/MDMA: Comparative effects on mood and cognition in recreational users. Open Addiction Journal 2011, 4:36-37.
42. Phillips M.R., Zhang J., Shi Q., Song Z., Ding Z., Pang S., et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: An epidemiological survey. Lancet 2009, 373:2041-2053.
43. Qian H.Z., Schumacher J.E., Chen H.T., Ruan Y.H. Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduct Journal 2006, 3:4.
44. Rawson R.A., Washton A., Domier C.P., Reiber C. Drugs and sexual effects: Role of drug type and gender. Journal of Substance Abuse Treatment 2002, 22:103-108.
45. Roth M.E., Cosgrove K.P., Carroll M.E. Sex differences in the vulnerability to drug abuse: A review of preclinical studies. Neuroscience and Biobehavioral Reviews 2004, 28:533-546.
46. Rusch M.L., Lozada R., Pollini R.A., Vera A., Patterson T.L., Case P., et al. Polydrug use among IDUs in Tijuana, Mexico: Correlates of methamphetamine use and route of administration by gender. Journal of Urban Health 2009, 86:760-775.
47. Scott K.M., Wells J.E., Angermeyer M., Brugha T.S., Bromet E., Demyttenaere K., et al. Gender and the relationship between marital status and first onset of mood, anxiety and substance use disorders. Psychological Medicine 2010, 40:1495-1505. 10.1017/S0033291709991942.
48. Seedat S., Scott K.M., Angermeyer M.C., Berglund P., Bromet E.J., Brugha T.S., et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Archives of General Psychiatry 2009, 66:785-795.
49. Simon S.L., Domier C., Carnell J., Brethen P., Rawson R., Ling W. Cognitive impairment in individuals currently using methamphetamine. The American Journal on Addictions 2000, 9:222-231.
50. Smith M.J., Thirthalli J., Abdallah A.B., Murray R.M., Cottler L.B. Prevalence of psychotic symptoms in substance users: A comparison across substances. Comprehensive Psychiatry 2009, 50:245-250.
51. Srisurapanont M., Ali R., Marsden J., Sunga A., Wada K., Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. The International Journal of Neuropsychopharmacology 2003, 6:347-352.
52. Su B.W., Heshmati A. Analysis of gender wage differential in China's urban labor market. IZA discussion paper No.6252 2011.
53. Thirthalli J., Benegal V. Psychosis among substance users. Current Opinion in Psychiatry 2006, 19:239-245.
54. Turner R.J., Gil A.G. Psychiatric and substance use disorders in South Florida: Racial/ethnic and gender contrasts in a young adult cohort. Archives of General Psychiatry 2002, 59:43-50.
55. Verheyden S.L., Hadfield J., Calin T., Curran H.V. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: Evidence of gender differences. Psychopharmacology 2002, 161:23-31.
56. WORLD DRUG REPORT Executive Summary United Nations Office on Drugs and Crime 2009.